The Peptide Database is a built-in reference tool containing clinical information about peptide medications commonly used in longevity and integrative medicine. It's designed to give prescribers quick access to the information they need without leaving Qliva.
The Peptide Database is a reference tool — it does not generate prescriptions. Use the Prescribing module to write scripts.
Who can access it
The Peptide Database is available to practitioners with prescribing scope: GPs, specialists, and endorsed nurses. Practitioners without prescribing scope will not see this feature in their sidebar or within the prescribing flow.
Where to find it
You can access the database in two ways:
| Access point | How to open it | Best for |
|---|---|---|
| Sidebar page | Click Peptide Database in the clinical sidebar | Browsing, research, reference outside a consult |
| Inline slide-over | Click the database icon from within a prescription | Looking something up while prescribing |
Use the inline slide-over while prescribing so you can reference the database and write the prescription on the same screen — no switching tabs or losing your place.
What's in the database
Each peptide entry contains:
- Mechanism of action — how the peptide works at a biological level
- Clinical indications — conditions and goals it's commonly used for
- Standard dosing protocols — typical dosing ranges and schedules
- Administration routes — subcutaneous, intranasal, oral, and others where applicable
- Common side effects — known adverse effects to discuss with patients
- Contraindications — situations where use is not appropriate
- Stacking protocols — common combinations used in clinical practice
- Storage requirements — temperature, light, and shelf-life guidance
Searching the database
Use the search bar to find peptides by name or indication. You can also browse by category if you're exploring options for a particular treatment goal.
Regulatory considerations
Many peptides are not TGA-registered medicines. Prescribing unapproved therapeutic goods in Australia may require special justification, patient consent, and regulatory compliance under the TGA's Authorised Prescriber or Special Access Scheme pathways. Always verify the regulatory status of a peptide before prescribing. Clinical and legal responsibility rests with the prescribing practitioner.
Database updates
The Peptide Database is maintained by the Qliva team. When entries are updated or new peptides are added, the changes appear automatically — no action is required from your clinic.